Your basket

No lines

£0.00

Drontal Wormer for Dogs & Cats

  • Cat XL » Priced Per Tablet £2.69
  • Cat » Priced Per Tablet £2.20
  • Plus Flavour Bone For Dogs » Priced Per Tablet £2.20
  • Plus Flavour XL for Dogs » Priced Per Tablet £7.00
  • Puppy Suspension » 50ml Bottle £13.00
  • Puppy Suspension » 100ml Bottle £22.99

Selection of 6 products from

£2.20 to £22.99

Intestinal worms, whether Roundworms or Tapeworms, can pose a potentially serious health threat to your cats if left untreated, so regular worming (every 3 months) is a necessity. In order to survive and multiply within the internal environment of your cat, worms will feed on the blood and content of the gut, with some laying dormant for up to a year within the muscle tissue, depositing an unprecedented number of eggs every day. This can lead to unpleasant symptoms of sickness, loss of appetite, diarrhoea and excessive bottom cleaning, however, sometimes worms are not accompanied by any diagnostic symptoms. Not only are worms a troublesome affliction for your cat, but they can be potentially hazardous for you if transferred through touching and licking, or picked up on your shoes and brought into the home. Drontal is an effective, economical worming treatment for dogs and cats, acting to safeguard your pet against the intrusion of harmful worms in the body, comprising an active ingredient that interferes with the energy metabolism of worms, causing them to die and pass out of the body.

Cat dosage

2 – 4kg= 1 x Drontal Cat Tablet

4 – 6kg= 1 x Drontal Cat XL Tablet

6 – 8kg= 2 x Drontal Cat Tablets

8 – 10kg= 1 x Drontal Cat & 1 x Drontal Cat XL Tablet

Dog Dosage

Dosage Guide:

½-2 kg bodyweight = ¼ Drontal Plus Flavour Tablet

2-5 kg bodyweight = ½ Drontal Plus Flavour Tablet

6-10 kg bodyweight = 1 Drontal Plus Flavour Tablet

11-15 kg bodyweight = 1½ Drontal Plus Flavour Tablet

16-20 kg bodyweight = 2 Drontal Plus Flavour Tablet

21-25 kg bodyweight = 2½ Drontal Plus Flavour Tablet

31 - 35 kg bodyweight = 1 tablet Drontal Plus XL

36 - 40 kg bodyweight = 1 Drontal Plus XL Tablet plus ½ tablet Drontal Plus Flavour

41 - 45 kg bodyweight = 1 Drontal Plus XL Tablet plus 1 tablet Drontal Plus Flavour

46 - 50 kg bodyweight = 1 Drontal Plus XL Tablet plus 1½ tablets Drontal Plus Flavour

51 - 55 kg bodyweight = 1 Drontal Plus XL Tablet plus 2 tablets Drontal Plus Flavour

56 - 60 kg bodyweight = 1 Drontal Plus XL Tablet plus 2½ tablet Drontal Plus

61 - 65 kg bodyweight = 1 Drontal Plus XL Tablet plus 3 tablets Drontal Plus Flavour

66 - 70 kg bodyweight = 2 Drontal Plus XL Tablets

Puppy Suspension

Please note, Drontal Puppy Suspension is only suitable for dogs up to one year old.

Drontal puppy suspension dosage, 1 ml per Kg bodyweight;To be given orally with or without food.

Drontal Cat Tablets

Presentation

Drontal Cat Film-coated Tablets are white to yellowish, scored, coated tablets that can be divided into equal halves. Each tablet contains 230 mg pyrantel embonate and 20 mg praziquantel with 1.8 mg Titanium Dioxide (E171).

Drontal Cat XL Film-coated Tablets are unscored coated white to yellowish, ellipsoid, biconvex tablets, each containing 345 mg pyrantel embonate and 30 mg praziquantel with 2.6 mg Titanium Dioxide (E171).

Uses

For the treatment of gastrointestinal roundworms and tapeworms of cats: Toxocara cati, Toxascaris leonina, Dipylidium caninum, Taenia taeniaeformis (see ‘Further information’).

Dosage and administration

Dosage

The recommended dose rates are 57.5 mg/kg pyrantel embonate and 5 mg/kg praziquantel. This is equivalent to one Drontal Cat Film-coated Tablet per 4 kg body weight and 1 Drontal Cat XL Film-coated Tablet per 6 kg body weight.

See dosage chart below for examples:

Weight of Cat

No of Drontal Cat Film-coated Tablets

No of Drontal Cat XL Film-coated Tablets

2 kg

½

-

4 kg

1

-

6 kg

or

1

8 kg

2

10 kg

1

plus

1

Administration and Duration of Treatment

For single oral administration. The tablets should be given directly to the animal, but if necessary can be disguised in food.

Use During Pregnancy and Lactation

Not to be used during pregnancy but may be used during lactation.

Contra-indications, warnings, etc

Not intended for use in kittens less than 6 weeks of age.

Do not use simultaneously with piperazine compounds.

Until sufficient studies have been performed with this combination, do not use during pregnancy.

User Safety

In the interests of good hygiene, persons administering the tablets directly to a cat, or by adding them to the cat’s food, should wash their hands afterwards.

For animal treatment only.

Keep out of the reach of children

Environmental Safety

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Pharmaceutical precautions

Do not store above 25°C.

Do not remove tablets from strip packing until required for use.

Any part-used tablets should be discarded.

Drontal Cat Film-coated Tablets: Shelf-life of the veterinary medicinal product as packaged for sale: 5 years.

Drontal Cat XL Film-coated Tablets: Shelf-life of the veterinary medicinal product as packaged for sale: 4 years.

Legal category

NFA-VPS

Packaging Quantities

Drontal® Cat Film-coated Tablets:

Cardboard cartons with polyethylene-coated aluminium foil blisters containing 2, 24 or 96 tablets in strips of 2 or 8 tablets.

Drontal® Cat XL Film-coated Tablets :

Cardboard cartons with polyethylene-coated aluminium foil blisters containing 2, 8, or 48 tablets in strips of 2 or 8 tablets.

Further information

An anthelmintic active against roundworms and tapeworms. ATC VetCode: QP52 AA51. Pharmacotherapeutic Group: Anthelmintics, Praziquantel combinations. The product contains two active ingredients, pyrantel embonate (pamoate) a tetrahydropyrimidine derivative and praziquantel a partially hydrogenated pyrazino-isoquinoline derivative

Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis and thereby allow expulsion from the gastro-intestinal (GI) system by peristalsis.

Praziquantel is very rapidly absorbed and distributed throughout the parasite. Both in vivo and in vitro studies have shown that praziquantel causes severe damage to the parasite integument, resulting in contraction and paralysis. There is an almost instantaneous tetanic contraction of the parasite musculature and a rapid vacuolisation of the syncytial tegument. This rapid contraction has been explained by changes in divalent cation fluxes, especially calcium.

In this fixed combination product, the pyrantel is active against the following ascarids: Toxocara cati, and Toxascaris leonina; the praziquantel is effective against tapeworms, in particular Dipylidium caninum and Taenia taeniaeformis.

The product has been shown to be efficacious in the control of hookworms Ancylostoma tubaeforme and A. braziliense and the tapeworm Joyeuxiella pasqualei, none of which occur naturally in cats in the UK but may occasionally be found in imported animals. Praziquantel is effective against Echinococcus multilocularis. E. multilocularis does not occur in the UK but is becoming more common in some European countries. As a precautionary measure to prevent establishment of E. multilocularis in the UK, it is recommended that all dogs and cats entering the country be treated with praziquantel.

Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. Tapeworm infection is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken.

Marketing authorisation number

Drontal® Cat Film-coated Tablets

Vm 00010/4094

Drontal® Cat XL Film-coated Tablets

Vm 00010/4135

GTIN (Global Trade Item No)

Drontal Cat Film-Coated Tablets (2 Tablets)

04007221033264

Drontal Cat Film-Coated Tablets (24 Tablets)

04007221033387

Drontal Cat Film-Coated Tablets (96 Tablets)

04007221033363

Drontal Cat XL Film-Coated Tablets (2 Tablets)

04007221033301

Drontal Cat XL Film-Coated Tablets (8 Tablets)

04007221033325

Drontal Cat XL Film-Coated Tablets (48 Tablets)

04007221033349

Drontal Plus Flavour Tablets

Presentation

Drontal Plus Flavour Tablets are a light brown to brown, round tablet, cross scored on one side for oral administration to dogs, containing 50 mg praziquantel, 144 mg pyrantel embonate and 150 mg febantel as active constituents and 116.5 mg Artificial beef flavour irradiated.

Drontal Plus XL Flavour Tablet is a pale brown to brown oval-shaped divisible tablet scored on both sides containing 175 mg praziquantel, 504 mg pyrantel embonate and 525 mg febantel as active constituents and 408.0 mg Artificial beef flavour irradiated.

Uses

For the control of the following gastrointestinal roundworms and tapeworms of dogs and puppies.

Ascarids

Toxocara canis, Toxascaris leonina (adult and late immature forms).

Hookworms

Uncinaria stenocephala, Ancylostoma caninum (adults).

Whipworms

Trichuris vulpis (adults).

Tapeworms

Echinococcus species, Taenia species, Dipylidium caninum (adults and immature forms).

Dosage and administration

For oral administration only.

The recommended dose rates are: 15 mg/kg body weight febantel, 14.4 mg/kg pyrantel and 5 mg/kg praziquantel.

1 Drontal Plus Flavour Tablet per 10 kg (22 lbs) body weight.

1 Drontal Plus XL Flavour Tablet per 35 kg body weight.

Dosage Guide

Drontal Plus Flavour Tablets

Puppies and Small Dogs:

3-5 kg body weight = ½ tablet

>5-10 kg body weight = 1 tablet

Medium Dogs:

>10-15 kg body weight = 1 ½ tablets

>15-20 kg body weight = 2 tablets

>20-25 kg body weight = 2 ½ tablets

>25-30 kg body weight = 3 tablets

Large Dogs:

>30-35 kg body weight = 3 ½ tablets

>35-40 kg body weight = 4 tablets

Dosage Guide

Drontal Plus XL Flavour Tablets

17.5 kg body weight = ½ tablet

>17.5 - 35 kg body weight = 1 tablet

>35 - 52.5 kg body weight = 1 ½ tablets

>52.5 - 70 kg body weight = 2 tablets

Drontal Plus Flavour Tablets should be used to achieve accurate dosing in dogs weighing less than 17.5 kg. The dose is equivalent to 1 tablet per 10 kg.

The tablets can be given directly to the dog or disguised in food. No starvation is needed before or after treatment.

For routine treatment a single dose is recommended.

Puppies should be treated at 2 weeks of age and every 2 weeks until 12 weeks of age. Thereafter they should be treated at 3 month intervals. It is advisable to treat the bitch at the same time as the puppies. Not for use in dogs weighing less than 3 kg.

For the control of Toxocara, nursing bitches should be dosed 2 weeks after giving birth and every two weeks until weaning.

For routine control adult dogs should be treated every 3 months. For routine treatment a single dose is recommended. In the event of heavy roundworm infection a repeat dose should be given after 14 days.

Use During Pregnancy and Lactation

Consult a veterinary surgeon before treating pregnant animals for roundworms.

The product may be used during lactation.

Do not exceed recommended dose when treating pregnant bitches.

Contra-indications, warnings, etc

Do not use simultaneously with piperazine compounds.

The product is well tolerated in dogs. In safety studies doses of 5 x or greater gave rise to occasional vomiting.

User safety

In the interests of good hygiene, persons administering the tablets directly to the dog, or by adding them to the dog's food, should wash their hands afterwards.

Environmental safety

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

Pharmaceutical precautions

Do not store above 25°C.

Any part-used tablets should be discarded.

Drontal Plus Flavour Tablets: Shelf-life of the veterinary medicinal product as packaged for sale: 5 years.

Drontal Plus XL Flavour Tablets: Shelf-life of the veterinary medicinal product as packaged for sale: 3 years.

Legal category

NFA-VPS

Packaging Quantities

Drontal Plus Flavour Tablets:

Carton containing polyethylene-coated aluminium foil blisters with 2, 8, 24, or 104 tablets.

Drontal Plus XL Flavour Tablets:

Carton containing a PCTFE/PVC- aluminium foil strip of 2, 8 or 48 tablets.

Further information

Pharmacotherapeutic group: Anthelmintics, tetrahydropyrimidine. ATC VetCodes: QP52AF30, QP52AC55.

The product contains three active substances active against roundworms and tapeworms: 1. Febantel, a probenzimidazole, 2. Pyrantel embonate (pamoate) a tetrahydropyrimidine derivative, 3. Praziquantel, a partially hydrogenated pyrazinoisoquinoline derivative.

Praziquantel is a partially hydrogenated pyrazino-isoquinoline derivative used widely as an anthelmintic for both human and veterinary use.

In this fixed combination pyrantel and febantel act against all relevant nematodes (ascarids, hookworms, and whipworms) in dogs. In particular the activity spectrum covers Toxocara canis, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum and Trichuris vulpis. This combination shows synergistic activity in the case of hookworms and febantel is effective against T.vulpis.

The spectrum of activity of praziquantel covers all important cestode species in dogs, in particular Taenia spp Dipylidium caninum, Echinococcus granulosus and Echinococcus multilocularis. Praziquantel acts against all adult and immature forms of these parasites.

Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis of the nematodes and thereby allow removal from the gastrointestinal system by peristalsis.

Within the mammalian system febantel undergoes ring closure forming fenbendazole and oxfendazole. It is these chemical entities which exert the anthelmintic effect by inhibition of tubulin polymerization. Formation of microtubules is thereby prevented, resulting in disruption of structures vital to the normal functioning of the helminth. Glucose uptake in particular is affected, leading to a depletion in cell ATP. The parasite dies upon exhaustion of its energy reserves, which occurs 2-3 days later.

Praziquantel is very rapidly absorbed through the parasite’s surface and distributed throughout the parasite. Both in vitro and in vivo studies have shown that praziquantel causes severe damage to the parasite integument, resulting in the contraction and paralysis of the parasites. There is an almost instantaneous tetanic contraction of the parasite musculature and a rapid vacuolization of the syncytial tegument. This rapid contraction has been explained by changes in divalent cation fluxes, especially calcium.

Since it contains praziquantel, the product is effective against Echinococcus multilocularis, which does not occur in the UK but is becoming more common in some European countries. As a precautionary measure to prevent establishment of E. multilocularis in the UK and Ireland, it is recommended that all dogs entering the country travelling either under the PETS scheme (UK only) or going into quarantine (UK & Ireland) be treated with praziquantel.

Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. Tapeworm infection is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken.

Marketing authorisation number

Drontal® Plus Flavour Tablets

Vm 00010/4158

Drontal® Plus XL Flavour Tablets

Vm 00010/4153

GTIN (Global Trade Item No)

Drontal Plus Flavour Tablets (2 Tablets)

04007221036111

Drontal Plus Flavour Tablets (8 Tablets)

04007221036142

Drontal Plus Flavour Tablets (24 Tablets)

04007221036166

Drontal Plus Flavour Tablets (104 Tablets)

04007221036180

Drontal Plus XL Flavour Tablets (2 Tablets)

04007221031390

Drontal Plus XL Flavour Tablets (8 Tablets)

04007221032205

Drontal Plus XL Flavour Tablets (48 Tablets)

04007221032298

Drontal Oral Suspension for Puppies

Presentation

A pale red suspension for oral administration. Each ml of suspension contains 5.0 mg Pyrantel (as pyrantel embonate 14.4 mg) and 15 mg febantel. The product also contains 2.05 mg sodium benzoate (E211), 2.05 mg sodium propionate (E281) and 0.25 mg Ponceau 4R (E124).

Uses

For the treatment of roundworm infections in puppies and young dogs up to one year of age caused by:

Ascarids

Toxocara canis, Toxascaris leonina

Hookworm

Ancylostoma caninum, Uncinaria stenocephala

Whipworm

Trichuris vulpis

Dosage and administration

The dose is 1 ml suspension/kg body weight (equivalent to 14.4 mg/kg pyrantel embonate and 15 mg/kg febantel).

Administration is by the oral route. The product may be given directly to the animal or mixed with the feed. No special dietary measures are necessary.

Mix the product by inversion of the container before withdrawing the required dose.

Through intrauterine and transmammary infection, ascarid infestation may occur in dogs at a very early age. For some animals, especially in case of severe infections, elimination of ascarids may be incomplete, and a potential risk of infections to humans can not be excluded. Where epidemiologically appropriate, it is recommended that treatment should be started at 2 weeks of age and should be performed repeatedly at suitable intervals (for example every two weeks) until weaning. Otherwise treatment should be based upon confirmed infection, for example the results of faecal examinations.

Use During Pregnancy and Lactation

This product is contra-indicated for pregnant and lactating bitches.

Contra-indications, warnings, etc

Do not use simultaneously with compounds containing piperazine.

Parasite resistance to any particular class of anthelmintic may develop following frequent repeated use of an anthelmintic of that class.

The safety of the product has not been assessed in puppies younger than 2 weeks and weighing less than 0.6 kg.

In very rare cases mild transient digestive tract signs (e.g., vomiting, diarrhoea) may occur.

The anthelmintic effects of both pyrantel (spastic paralysis) and piperazine (neuromuscular paralysis) may be antagonised when the two drugs are used together.

Doses of up to 5 times the therapeutic level of the product have been administered to puppies and young dogs without clinical signs of intolerance arising. At 10 times the recommended dose the first sign of intolerance – vomiting – was evident.

User safety

Wash hands after use.

Avoid direct contact with the skin and eyes.

In case of accidental spillage wash the affected area immediately with clean running water.

Environmental safety

Any unused product or waste materials should be disposed of in accordance with national requirements.

Pharmaceutical precautions

This unopened veterinary medicinal product does not require any special storage conditions.

After opening, store the product at a temperature not exceeding 25 ºC.

Do not use after expiry date.

Shelf-life of the veterinary medicinal product as packaged for sale: 5 years.

Shelf-life after first opening the immediate packaging: 12 weeks.

Legal category

NFA-VPS

Packaging Quantities

White high density polyethylene bottles of 50 ml and 100 ml with a white polyethylene screw closure and colourless low density polyethylene adapter insert.

Devices supplied: 5ml transparent polypropylene syringe with rubber plunger.

Further information

Fixed combination of two anthelmintics: a tetrahydropyrimidine derivative, pyrantel (as the embonate) and a pro-benzimidazole, febantel. ATCvet code QP52AF02.

In this fixed combination product, the pyrantel and febantel act synergistically against nematodes (ascarids, hookworms and whipworms) of dogs. In particular, the spectrum of activity covers Toxocara canis, Ancylostoma caninum and Trichuris vulpis. Published data are also available to confirm that Toxascaris leonina and Uncinaria stenocephala are also susceptible to this particular combination of actives.

Febantel, N-{2-[2,3-bis,(methoxycarbonyl)-guanidino]-5-(phenylthio) phenyl}-2-methoxyacetamide, is a pro-benzimidazole. Within the mammalian system febantel undergoes ring closure forming fenbendazole and oxfendazole. It is these chemical entities which exert the anthelmintic effect by inhibition of tubulin polymerization. Formation of microtubules is thereby prevented, resulting in disruption to structures vital to the normal functioning of the helminth. Glucose uptake, in particular, is affected, leading to depletion in cell ATP. The parasite dies upon exhaustion of its energy reserves, which occurs 2-3 days later. Pyrantel, (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl) vinyl] pyrimidine pamoate belongs to the tetrahydropyrimidine type. Its mode of action is to stimulate nicotinic cholinergic receptors inducing spastic paralysis and thereby allowing removal from the gastro-intestinal (GI) system by peristalsis.

Literature reports indicate after oral application of the recommended dose of 1 ml/kg bodyweight (corresponding to 14.4mg/kg pyrantel embonate and 15 mg/kg febantel) maximum serum concentrations for febantel were found between 1 and 6 hours with a Cmax of 0.019 mg/l two hours after dosing. As febantel, as a pro-drug, is metabolised to fenbendazole which is further converted to oxfendazole, also these metabolites were measured. Cmax of febendazole was 0.130 mg/l after 3 hours and Cmax of oxfendazole was 0.157 mg/l at about 5 hours after application.

The Cmax of pyrantel (measured as pyrantel base) was 0.084 mg/l 2.5 hours after application.

Marketing authorisation number

Vm 00010/4102

GTIN (Global Trade Item No)

Drontal Oral Suspension for Puppies (50ml)

04007221025023

Drontal Oral Suspension for Puppies (100ml)

04007721025016

Need help or advice? Contact us:


All prices include VAT where applicable.

Reviews of Drontal Wormer for Dogs & Cats

Read our customers' reviews of Drontal Wormer for Dogs & Cats

Questions & Answers for Drontal Wormer for Dogs & Cats

Below are some recent questions we've received regarding Drontal Wormer for Dogs & Cats, including answers from our team.

Ask Your Own Question

Wormer for cats

28th Sep 2015
Caroline Heaney

My cat is 6.5kg. What amount of wormer do I use and how long does it last?

  • Non-Executive Director

I would give a single Drontal XL tablet and ideally repeat this every 3 months.